Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma

Shigeki Sekine, Reiko Ogawa, Taihei Oshiro, Yukihide Kanemitsu, Hirokazu Taniguchi, Ryoji Kushima, Yae Kanai

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Colorectal villous adenoma is thought to be associated with a high risk of progression to adenocarcinoma. To better characterize the genetic alterations involved in colorectal carcinogenesis related to villous adenoma, we analyzed mutations in APC, BRAF, KRAS, TP53, and GNAS in 12 colorectal adenocarcinomas associated with villous adenomas. APC, KRAS, and BRAF mutations were identified in five, 11, and one lesion, respectively, and most of these mutations were shared between the villous adenoma and the adenocarcinoma components in the respective lesions, except in one lesion with APC mutations and in two lesions with KRAS mutations. TP53 mutations were observed exclusively in four adenocarcinoma components, consistent with their role in the progression from adenoma to adenocarcinoma. Activating GNAS mutations were found in nine villous adenomas; however, unexpectedly, these mutations were shared only in three associated adenocarcinomas. Notably, all six adenocarcinomas with discordant GNAS mutation statuses were nonmucinous type, whereas all the other adenocarcinomas, including three adenocarcinomas associated with GNAS wild-type villous adenomas, were mucinous type. The current study suggests that GNAS-mutated villous adenomas may not necessarily be direct precursors of associated adenocarcinomas. At the same time, our observations support the role of activating GNAS mutations in increased mucin production in colorectal neoplasms.

Original languageEnglish
Pages (from-to)366-372
Number of pages7
JournalGenes Chromosomes and Cancer
Volume53
Issue number4
DOIs
Publication statusPublished - 2014 Apr
Externally publishedYes

Fingerprint

Villous Adenoma
Adenocarcinoma
Mutation
Mucins
Adenoma
Colorectal Neoplasms
Carcinogenesis

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma. / Sekine, Shigeki; Ogawa, Reiko; Oshiro, Taihei; Kanemitsu, Yukihide; Taniguchi, Hirokazu; Kushima, Ryoji; Kanai, Yae.

In: Genes Chromosomes and Cancer, Vol. 53, No. 4, 04.2014, p. 366-372.

Research output: Contribution to journalArticle

Sekine, Shigeki ; Ogawa, Reiko ; Oshiro, Taihei ; Kanemitsu, Yukihide ; Taniguchi, Hirokazu ; Kushima, Ryoji ; Kanai, Yae. / Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma. In: Genes Chromosomes and Cancer. 2014 ; Vol. 53, No. 4. pp. 366-372.
@article{257d1061934842efbb015a7b801a76f8,
title = "Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma",
abstract = "Colorectal villous adenoma is thought to be associated with a high risk of progression to adenocarcinoma. To better characterize the genetic alterations involved in colorectal carcinogenesis related to villous adenoma, we analyzed mutations in APC, BRAF, KRAS, TP53, and GNAS in 12 colorectal adenocarcinomas associated with villous adenomas. APC, KRAS, and BRAF mutations were identified in five, 11, and one lesion, respectively, and most of these mutations were shared between the villous adenoma and the adenocarcinoma components in the respective lesions, except in one lesion with APC mutations and in two lesions with KRAS mutations. TP53 mutations were observed exclusively in four adenocarcinoma components, consistent with their role in the progression from adenoma to adenocarcinoma. Activating GNAS mutations were found in nine villous adenomas; however, unexpectedly, these mutations were shared only in three associated adenocarcinomas. Notably, all six adenocarcinomas with discordant GNAS mutation statuses were nonmucinous type, whereas all the other adenocarcinomas, including three adenocarcinomas associated with GNAS wild-type villous adenomas, were mucinous type. The current study suggests that GNAS-mutated villous adenomas may not necessarily be direct precursors of associated adenocarcinomas. At the same time, our observations support the role of activating GNAS mutations in increased mucin production in colorectal neoplasms.",
author = "Shigeki Sekine and Reiko Ogawa and Taihei Oshiro and Yukihide Kanemitsu and Hirokazu Taniguchi and Ryoji Kushima and Yae Kanai",
year = "2014",
month = "4",
doi = "10.1002/gcc.22147",
language = "English",
volume = "53",
pages = "366--372",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma

AU - Sekine, Shigeki

AU - Ogawa, Reiko

AU - Oshiro, Taihei

AU - Kanemitsu, Yukihide

AU - Taniguchi, Hirokazu

AU - Kushima, Ryoji

AU - Kanai, Yae

PY - 2014/4

Y1 - 2014/4

N2 - Colorectal villous adenoma is thought to be associated with a high risk of progression to adenocarcinoma. To better characterize the genetic alterations involved in colorectal carcinogenesis related to villous adenoma, we analyzed mutations in APC, BRAF, KRAS, TP53, and GNAS in 12 colorectal adenocarcinomas associated with villous adenomas. APC, KRAS, and BRAF mutations were identified in five, 11, and one lesion, respectively, and most of these mutations were shared between the villous adenoma and the adenocarcinoma components in the respective lesions, except in one lesion with APC mutations and in two lesions with KRAS mutations. TP53 mutations were observed exclusively in four adenocarcinoma components, consistent with their role in the progression from adenoma to adenocarcinoma. Activating GNAS mutations were found in nine villous adenomas; however, unexpectedly, these mutations were shared only in three associated adenocarcinomas. Notably, all six adenocarcinomas with discordant GNAS mutation statuses were nonmucinous type, whereas all the other adenocarcinomas, including three adenocarcinomas associated with GNAS wild-type villous adenomas, were mucinous type. The current study suggests that GNAS-mutated villous adenomas may not necessarily be direct precursors of associated adenocarcinomas. At the same time, our observations support the role of activating GNAS mutations in increased mucin production in colorectal neoplasms.

AB - Colorectal villous adenoma is thought to be associated with a high risk of progression to adenocarcinoma. To better characterize the genetic alterations involved in colorectal carcinogenesis related to villous adenoma, we analyzed mutations in APC, BRAF, KRAS, TP53, and GNAS in 12 colorectal adenocarcinomas associated with villous adenomas. APC, KRAS, and BRAF mutations were identified in five, 11, and one lesion, respectively, and most of these mutations were shared between the villous adenoma and the adenocarcinoma components in the respective lesions, except in one lesion with APC mutations and in two lesions with KRAS mutations. TP53 mutations were observed exclusively in four adenocarcinoma components, consistent with their role in the progression from adenoma to adenocarcinoma. Activating GNAS mutations were found in nine villous adenomas; however, unexpectedly, these mutations were shared only in three associated adenocarcinomas. Notably, all six adenocarcinomas with discordant GNAS mutation statuses were nonmucinous type, whereas all the other adenocarcinomas, including three adenocarcinomas associated with GNAS wild-type villous adenomas, were mucinous type. The current study suggests that GNAS-mutated villous adenomas may not necessarily be direct precursors of associated adenocarcinomas. At the same time, our observations support the role of activating GNAS mutations in increased mucin production in colorectal neoplasms.

UR - http://www.scopus.com/inward/record.url?scp=84894070638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894070638&partnerID=8YFLogxK

U2 - 10.1002/gcc.22147

DO - 10.1002/gcc.22147

M3 - Article

VL - 53

SP - 366

EP - 372

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 4

ER -